Lobe Sciences Ltd. Acquires Securities of Ionic Brands Corp.
February 3, 2022
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders
December 15, 2021